The Course
Hormone disorders across the reproductive years are common, yet frequently misunderstood, misdiagnosed, or treated in isolation. From PCOS and PMDD to progesterone intolerance, perinatal mood disorders, and the early stages of perimenopause, clinicians are often left without a cohesive framework for care.
Mastering Pre-Menopausal Hormone Disorders provides a comprehensive, neuroendocrinology-grounded approach to understanding and managing hormone conditions that occur across the female reproductive lifespan. This course emphasizes pattern recognition, diagnostic clarity, and evidence-based treatment strategies that translate directly to clinical practice.
What you will learn
By the end of this course, participants will be able to:
- Understand the female reproductive-cycle neuroendocrinology spectrum and how hormone disorders evolve over time
- Identify and manage common and complex presentations of PCOS, including diagnostic criteria and treatment options
- Recognize peri- and postnatal mood disorders, differentiate anxiety and depressive syndromes, and apply appropriate support strategies
- Evaluate progesterone intolerance and disorders, including symptom patterns and treatment approaches
- Diagnose and treat PMDD, using evidence-based frameworks
- Confidently assess and manage perimenopause, including diagnostic criteria and therapeutic options
- Apply a longitudinal, life-course approach to hormone care rather than siloed symptom management
Curriculum
Frequently Asked Questions
When does the course start?
Live sessions begin February 11th, with programming continuing through June. See dates and topics in the Curriculum section.
Is this course live or self-paced?
This live, multi-session course includes focused teaching modules paired with interactive Q&A sessions to deepen clinical application. Recordings will be available.
How long do I have access?
Participants receive ongoing access to course materials and recordings.
Who is this course for?
This course is designed for clinicians caring for patients with hormone-related conditions, including prescribers and advanced practice providers.